Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation

Abstract

DDX3X is a DEAD-box RNA helicase that has been implicated in multiple aspects of RNA metabolism including translation initiation and the assembly of stress granules (SGs). Recent genomic studies have reported recurrent DDX3X mutations in numerous tumors including medulloblastoma (MB), but the physiological impact of these mutations is poorly understood. Here we show that a consistent feature of MB-associated mutations is SG hyper-assembly and concomitant translation impairment. We used CLIP-seq to obtain a comprehensive assessment of DDX3X binding targets and ribosome profiling for high-resolution assessment of global translation. Surprisingly, mutant DDX3X expression caused broad inhibition of translation that impacted DDX3X targeted and non-targeted mRNAs alike. Assessment of translation efficiency with single-cell resolution revealed that SG hyper-assembly correlated precisely with impaired global translation. SG hyper-assembly and translation impairment driven by mutant DDX3X were rescued by a genetic approach that limited SG assembly and by deletion of the N-terminal low complexity domain within DDX3X. Thus, in addition to a primary defect at the level of translation initiation caused by DDX3X mutation, SG assembly itself contributes to global translation inhibition. This work provides mechanistic insights into the consequences of cancer-related DDX3X mutations, suggesting that globally reduced translation may provide a context-dependent survival advantage that must be considered as a possible contributor to tumorigenesis.

References 62

1. 1.

   Linder P. & Jankowsky E. From unwinding to clamping - the DEAD box RNA helicase family. Nat Rev Mol Cell Biol 12, 505–516, (2011 ).

   Not in our library10.1038/nrm3154

2. 2.

   Brandimarte L. et al. DDX3X-MLLT10 fusion in adults with NOTCH1 positive T-cell acute lymphoblastic leukemia. Haematologica 99, 64–66, (2014 ).

   Not in our library10.3324/haematol.2013.101725

3. 3.

   Brandimarte L. et al. New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia. Blood 121, 5064–5067, (2013 ).

   Not in our library10.1182/blood-2013-02-487256

4. 4.

   Landau D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525–530, (2015 ).

   Not in our library10.1038/nature15395

5. 5.

   Ojha J. et al. Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia. Br J Haematol 169, 445–448, (2015 ).

   Not in our library10.1111/bjh.13211

6. 6.

   Wang L. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 365, 2497–2506, (2011 ).

   Not in our library10.1056/nejmoa1109016

7. 7.

   Jiang L. et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma. Nat Genet, (2015 ).

   Not in our library10.1038/ng.3358

8. 8.

   Stransky N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157–1160, (2011 ).

   Not in our library10.1126/science.1208130

9. 9.
   Targeting DDX3 with a small molecule inhibitor for lung cancer therapy · 2015

   No notice
10. 10.

    Kandoth C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333–339, (2013 ).

    Not in our library10.1038/nature12634

11. 11.

    Pugh T. J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106–110, (2012 ).

    Not in our library10.1038/nature11329

12. 12.

    Robinson G. et al. Novel mutations target distinct subgroups of medulloblastoma. Nature 488, 43–48, (2012 ).

    Not in our library10.1038/nature11213

13. 13.

    Jones D. T. et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100–105, (2012 ).

    Not in our library10.1038/nature11284

14. 14.

    Northcott P. A. et al. Medulloblastomics: the end of the beginning. Nat Rev Cancer 12, 818–834, (2012 ).

    Not in our library10.1038/nrc3410

15. 15.

    Kool M. et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25, 393–405, (2014 ).

    Not in our library10.1016/j.ccr.2014.02.004

16. 16.

    Botlagunta M. et al. Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene 27, 3912–3922, (2008 ).

    Not in our library10.1038/onc.2008.33

17. 17.

    Wu D. W. et al. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer. Clin Cancer Res 17, 1895–1905, (2011 ).

    Not in our library10.1158/1078-0432.ccr-10-2316

18. 18.

    Chao C. H. et al. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res 66, 6579–6588, (2006 ).

    Not in our library10.1158/0008-5472.can-05-2415

19. 19.

    Miao X. et al. Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. Int J Clin Exp Pathol 6, 179–190 (2013 ).

    Not in our library

20. 20.

    Heerma van Voss M. R. et al. DDX3 has divergent roles in head and neck squamous cell carcinomas in smoking versus non-smoking patients. Oral Dis 21, 270–271, (2015 ).

    Not in our library10.1111/odi.12299

21. 21.

    Soulat D. et al. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J 27, 2135–2146, (2008 ).

    Not in our library10.1038/emboj.2008.126

22. 22.

    Merz C., Urlaub H., Will C. L. & Luhrmann R. Protein composition of human mRNPs spliced in vitro and differential requirements for mRNP protein recruitment. RNA 13, 116–128, (2007 ).

    Not in our library10.1261/rna.336807

23. 23.

    Stevens S. W. et al. Composition and functional characterization of the yeast spliceosomal penta-snRNP. Mol Cell 9, 31–44 (2002 ).

    Not in our library10.1016/s1097-2765(02)00436-7

24. 24.

    Yedavalli V. S., Neuveut C., Chi Y. H., Kleiman L. & Jeang K. T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119, 381–392, (2004 ).

    Not in our library10.1016/j.cell.2004.09.029

25. 25.

    Lai M. C., Lee Y. H. & Tarn W. Y. The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control. Mol Biol Cell 19, 3847–3858, (2008 ).

    Not in our library10.1091/mbc.e07-12-1264

26. 26.

    Chuang R. Y., Weaver P. L., Liu Z. & Chang T. H. Requirement of the DEAD-Box protein ded1p for messenger RNA translation. Science 275, 1468–1471 (1997 ).

    Not in our library10.1126/science.275.5305.1468

27. 27.

    de la Cruz J., Iost I., Kressler D. & Linder P. The p20 and Ded1 proteins have antagonistic roles in eIF4E-dependent translation in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 94, 5201–5206 (1997 ).

    Not in our library10.1073/pnas.94.10.5201

28. 28.

    Berthelot K., Muldoon M., Rajkowitsch L., Hughes J. & McCarthy J. E. Dynamics and processivity of 40S ribosome scanning on mRNA in yeast. Mol Microbiol 51, 987–1001 (2004 ).

    Not in our library10.1046/j.1365-2958.2003.03898.x

29. 29.

    Marsden S., Nardelli M., Linder P. & McCarthy J. E. Unwinding single RNA molecules using helicases involved in eukaryotic translation initiation. J Mol Biol 361, 327–335, (2006 ).

    Not in our library10.1016/j.jmb.2006.06.016

30. 30.

    Lee C. S. et al. Human DDX3 functions in translation and interacts with the translation initiation factor eIF3. Nucleic Acids Res 36, 4708–4718, (2008 ).

    Not in our library10.1093/nar/gkn454

31. 31.

    Ihry R. J., Sapiro A. L. & Bashirullah A. Translational control by the DEAD Box RNA helicase belle regulates ecdysone-triggered transcriptional cascades. PLoS Genet 8, e1003085, (2012 ).

    Not in our library10.1371/journal.pgen.1003085

32. 32.

    Beckham C. et al. The DEAD-box RNA helicase Ded1p affects and accumulates in Saccharomyces cerevisiae P-bodies. Mol Biol Cell 19, 984–993, (2008 ).

    Not in our library10.1091/mbc.e07-09-0954

33. 33.

    Goulet I., Boisvenue S., Mokas S., Mazroui R. & Cote J. TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules. Hum Mol Genet 17, 3055–3074, (2008 ).

    Not in our library10.1093/hmg/ddn203

34. 34.

    Shih J. W. et al. Critical roles of RNA helicase DDX3 and its interactions with eIF4E/PABP1 in stress granule assembly and stress response. Biochem J 441, 119–129, (2012 ).

    Not in our library10.1042/bj20110739

35. 35.

    Elbaum-Garfinkle S. et al. The disordered P granule protein LAF-1 drives phase separation into droplets with tunable viscosity and dynamics. Proc Natl Acad Sci USA 112, 7189–7194, (2015 ).

    Not in our library10.1073/pnas.1504822112

36. 36.

    Anderson P. & Kedersha N. RNA granules. J Cell Biol 172, 803–808, (2006 ).

    Not in our library10.1083/jcb.200512082

37. 37.

    Buchan J. R. & Parker R. Eukaryotic stress granules: the ins and outs of translation. Mol Cell 36, 932–941, (2009 ).

    Not in our library10.1016/j.molcel.2009.11.020

38. 38.

    Hilliker A., Gao Z., Jankowsky E. & Parker R. The DEAD-box protein Ded1 modulates translation by the formation and resolution of an eIF4F-mRNA complex. Mol Cell 43, 962–972, (2011 ).

    Not in our library10.1016/j.molcel.2011.08.008

39. 39.

    Lin Y., Protter D. S., Rosen M. K. & Parker R. Formation and Maturation of Phase-Separated Liquid Droplets by RNA-Binding Proteins. Mol Cell 60, 208–219, (2015 ).

    Not in our library10.1016/j.molcel.2015.08.018

40. 40.

    Xiang S. et al. The LC Domain of hnRNPA2 Adopts Similar Conformations in Hydrogel Polymers, Liquid-like Droplets, and Nuclei. Cell 163, 829–839, (2015 ).

    Not in our library10.1016/j.cell.2015.10.040

Cited by papers we hold 7

• Liquid–liquid phase separation in tumor biology · 2022
  No notice
• Dynamic arrest and aging of biomolecular condensates are modulated by low-complexity domains, RNA and biochemical activity · 2022
  No notice
• Protein condensation diseases: therapeutic opportunities · 2022
  No notice
• DDX3X: structure, physiologic functions and cancer · 2021
  No notice
• DDX3 depletion represses translation of mRNAs with complex 5′ UTRs · 2021
  No notice
• X Inactivation and Escape: Epigenetic and Structural Features · 2019
  No notice
• Analysis of NRAS RNA G-quadruplex binding proteins reveals DDX3X as a novel interactor of cellular G-quadruplex containing transcripts · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.